Pediatrix Medical Group Analyst Ratings
Pediatrix Medical Group Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/11/2023 | 20.87% | Truist Securities | $16 → $15 | Maintains | Hold |
| 05/09/2023 | 20.87% | Truist Securities | $17 → $15 | Maintains | Hold |
| 02/22/2023 | 85.33% | Credit Suisse | $27 → $23 | Maintains | Outperform |
| 12/05/2022 | 117.57% | Credit Suisse | $28 → $27 | Maintains | Outperform |
| 11/16/2022 | 36.99% | Mizuho | $21 → $17 | Maintains | Neutral |
| 11/04/2022 | 28.93% | SVB Leerink | $20 → $16 | Maintains | Market Perform |
| 08/11/2022 | 125.62% | Credit Suisse | $30 → $28 | Maintains | Outperform |
| 08/10/2022 | 85.33% | BMO Capital | $25 → $23 | Maintains | Market Perform |
| 05/12/2022 | 61.16% | SVB Leerink | $24 → $20 | Maintains | Market Perform |
| 05/03/2022 | 141.74% | Credit Suisse | $31 → $30 | Maintains | Outperform |
| 05/02/2022 | 85.33% | Mizuho | $28 → $23 | Maintains | Neutral |
| 04/27/2022 | 93.39% | SVB Leerink | $27 → $24 | Maintains | Market Perform |
| 02/23/2022 | 149.8% | Credit Suisse | $32 → $31 | Maintains | Outperform |
| 12/22/2021 | 157.86% | Credit Suisse | $33 → $32 | Maintains | Outperform |
| 11/04/2021 | 117.57% | SVB Leerink | $29 → $27 | Maintains | Market Perform |
| 09/27/2021 | 133.68% | SVB Leerink | → $29 | Initiates Coverage On | → Market Perform |
| 08/09/2021 | 157.86% | Mizuho | $30 → $32 | Maintains | Neutral |
| 05/24/2021 | 173.97% | Citigroup | $22 → $34 | Maintains | Neutral |
| 05/10/2021 | 93.39% | Deutsche Bank | $17.5 → $24 | Maintains | Sell |
| 02/19/2021 | 101.45% | Credit Suisse | $26 → $25 | Maintains | Outperform |
| 10/19/2020 | -3.3% | Deutsche Bank | $20 → $12 | Downgrades | Hold → Sell |
| 10/06/2020 | 12.81% | UBS | $11 → $14 | Maintains | Sell |
| 06/08/2020 | 93.39% | Credit Suisse | $20 → $24 | Maintains | Outperform |
| 05/21/2020 | 36.99% | SunTrust Robinson Humphrey | $15 → $17 | Maintains | Hold |
| 05/11/2020 | 20.87% | CFRA | $22 → $15 | Maintains | Hold |
| 05/11/2020 | 61.16% | Credit Suisse | $22 → $20 | Maintains | Outperform |
| 05/08/2020 | -11.36% | UBS | $18 → $11 | Maintains | Sell |
| 04/21/2020 | 28.93% | Baird | $21 → $16 | Maintains | Neutral |
| 04/13/2020 | 20.87% | SunTrust Robinson Humphrey | $22 → $15 | Maintains | Hold |
| 03/26/2020 | 77.28% | Credit Suisse | $29 → $22 | Maintains | Outperform |
| 03/03/2020 | 69.22% | Baird | $24 → $21 | Maintains | Neutral |
| 02/24/2020 | 133.68% | Credit Suisse | $33 → $29 | Maintains | Outperform |
| 02/24/2020 | 61.16% | JP Morgan | $33 → $20 | Maintains | Neutral |
| 02/21/2020 | 77.28% | Mizuho | $25 → $22 | Maintains | Neutral |
| 02/21/2020 | 85.33% | Citigroup | $29 → $23 | Maintains | Neutral |
| 01/03/2020 | 133.68% | Citigroup | → $29 | Downgrades | Buy → Neutral |
| 12/20/2019 | 165.91% | JP Morgan | $26 → $33 | Maintains | Neutral |
| 12/18/2019 | 141.74% | SunTrust Robinson Humphrey | $27 → $30 | Maintains | Hold |
| 12/12/2019 | 165.91% | Stifel | $25 → $33 | Upgrades | Hold → Buy |
| 10/18/2019 | 45.04% | UBS | $19 → $18 | Maintains | Sell |
| 09/06/2019 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 08/27/2019 | 125.62% | Credit Suisse | $30 → $28 | Maintains | Outperform |
| 08/05/2019 | 101.45% | BMO Capital | $32 → $25 | Maintains | Market Perform |
| 08/02/2019 | 93.39% | Mizuho | $26 → $24 | Maintains | Neutral |
| 02/13/2019 | 238.44% | Credit Suisse | $44 → $42 | Maintains | Outperform |
| 01/15/2019 | — | Citigroup | Upgrades | Neutral → Buy | |
| 01/03/2019 | 173.97% | Deutsche Bank | → $34 | Initiates Coverage On | → Hold |
| 11/16/2018 | 198.15% | UBS | → $37 | Initiates Coverage On | → Sell |
| 11/06/2018 | 302.9% | Credit Suisse | $55 → $50 | Maintains | Outperform |
| 11/02/2018 | 222.32% | Baird | $48 → $40 | Maintains | Neutral |
| 11/02/2018 | 246.49% | BMO Capital | $48 → $43 | Maintains | Market Perform |
| 10/19/2018 | 286.78% | Baird | $50 → $48 | Maintains | Neutral |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年10月11日 | 20.87% | Truist證券 | $16→$15 | 維護 | 保持 |
| 05/09/2023 | 20.87% | Truist證券 | $17→$15 | 維護 | 保持 |
| 02/22/2023 | 85.33% | 瑞士信貸 | $27→$23 | 維護 | 跑贏大盤 |
| 12/05/2022 | 117.57% | 瑞士信貸 | $28→$27 | 維護 | 跑贏大盤 |
| 2022年11月16日 | 36.99% | 瑞穗 | $21→$17 | 維護 | 中性 |
| 11/04/2022 | 28.93% | SVB Leerink | $20→$16 | 維護 | 市場表現 |
| 2022年08月11日 | 125.62% | 瑞士信貸 | $30→$28 | 維護 | 跑贏大盤 |
| 2022年08月10日 | 85.33% | 蒙特利爾銀行資本 | $25→$23 | 維護 | 市場表現 |
| 2022年05月12日 | 61.16% | SVB Leerink | $24→$20 | 維護 | 市場表現 |
| 05/03/2022 | 141.74% | 瑞士信貸 | $31→$30 | 維護 | 跑贏大盤 |
| 05/02/2022 | 85.33% | 瑞穗 | $28→$23 | 維護 | 中性 |
| 04/27/2022 | 93.39% | SVB Leerink | $27→$24 | 維護 | 市場表現 |
| 02/23/2022 | 149.8% | 瑞士信貸 | $32→$31 | 維護 | 跑贏大盤 |
| 2021年12月22日 | 157.86% | 瑞士信貸 | $33→$32 | 維護 | 跑贏大盤 |
| 11/04/2021 | 117.57% | SVB Leerink | $29→$27 | 維護 | 市場表現 |
| 09/27/2021 | 133.68% | SVB Leerink | →$29 | 開始承保 | →市場表現 |
| 08/09/2021 | 157.86% | 瑞穗 | $30→$32 | 維護 | 中性 |
| 2021/05/24 | 173.97% | 花旗集團 | $22→$34 | 維護 | 中性 |
| 2021/05/10 | 93.39% | 德意志銀行 | $17.5→$24 | 維護 | 賣 |
| 02/19/2021 | 101.45% | 瑞士信貸 | $26→$25 | 維護 | 跑贏大盤 |
| 10/19/2020 | -3.3% | 德意志銀行 | $20→$12 | 評級下調 | 持有→Sell |
| 10/06/2020 | 12.81% | 瑞銀集團 | $11→$14 | 維護 | 賣 |
| 06/08/2020 | 93.39% | 瑞士信貸 | $20→$24 | 維護 | 跑贏大盤 |
| 2020/05/21 | 36.99% | SunTrust Robinson Humphrey | $15→$17 | 維護 | 保持 |
| 05/11/2020 | 20.87% | CFRA | $22→$15 | 維護 | 保持 |
| 05/11/2020 | 61.16% | 瑞士信貸 | $22→$20 | 維護 | 跑贏大盤 |
| 05/08/2020 | -11.36% | 瑞銀集團 | $18→$11 | 維護 | 賣 |
| 04/21/2020 | 28.93% | 貝爾德 | $21→$16 | 維護 | 中性 |
| 04/13/2020 | 20.87% | SunTrust Robinson Humphrey | $22→$15 | 維護 | 保持 |
| 03/26/2020 | 77.28% | 瑞士信貸 | $29→$22 | 維護 | 跑贏大盤 |
| 03/03/2020 | 69.22% | 貝爾德 | $24→$21 | 維護 | 中性 |
| 02/24/2020 | 133.68% | 瑞士信貸 | $33→$29 | 維護 | 跑贏大盤 |
| 02/24/2020 | 61.16% | 摩根大通 | $33→$20 | 維護 | 中性 |
| 02/21/2020 | 77.28% | 瑞穗 | $25→$22 | 維護 | 中性 |
| 02/21/2020 | 85.33% | 花旗集團 | $29→$23 | 維護 | 中性 |
| 1/03/2020 | 133.68% | 花旗集團 | →$29 | 評級下調 | 購買→中性 |
| 2019年12月20日 | 165.91% | 摩根大通 | $26→$33 | 維護 | 中性 |
| 2019年12月18日 | 141.74% | SunTrust Robinson Humphrey | $27→$30 | 維護 | 保持 |
| 2019年12月12日 | 165.91% | Stifel | $25→$33 | 升級 | 持有→購買 |
| 2019年10月18日 | 45.04% | 瑞銀集團 | $19→$18 | 維護 | 賣 |
| 2019年06月09日 | - | B of A證券 | 評級下調 | 中性→表現不佳 | |
| 2019年08月27日 | 125.62% | 瑞士信貸 | $30→$28 | 維護 | 跑贏大盤 |
| 2019年08月05日 | 101.45% | 蒙特利爾銀行資本 | $32→$25 | 維護 | 市場表現 |
| 2019年08月02日 | 93.39% | 瑞穗 | $26→$24 | 維護 | 中性 |
| 2019年02月13日 | 238.44% | 瑞士信貸 | $44→$42 | 維護 | 跑贏大盤 |
| 2019年01月15日 | - | 花旗集團 | 升級 | 中性→購買 | |
| 2019年03月01日 | 173.97% | 德意志銀行 | →$34 | 開始承保 | →保留 |
| 2018年11月16日 | 198.15% | 瑞銀集團 | →$37 | 開始承保 | →銷售 |
| 2018/06/11 | 302.9% | 瑞士信貸 | $55→$50 | 維護 | 跑贏大盤 |
| 11/02/2018 | 222.32% | 貝爾德 | $48→$40 | 維護 | 中性 |
| 11/02/2018 | 246.49% | 蒙特利爾銀行資本 | $48→$43 | 維護 | 市場表現 |
| 2018年10月19日 | 286.78% | 貝爾德 | $50→$48 | 維護 | 中性 |
What is the target price for Pediatrix Medical Group (MD)?
兒科醫療集團(MD)的目標價格是多少？
The latest price target for Pediatrix Medical Group (NYSE: MD) was reported by Truist Securities on October 11, 2023. The analyst firm set a price target for $15.00 expecting MD to rise to within 12 months (a possible 20.87% upside). 6 analyst firms have reported ratings in the last year.
Truist Securities於2023年10月11日報道了Pediatrix Medical Group(紐約證券交易所代碼：MD)的最新目標價。這家分析公司將目標價定為15美元，預計MD將在12個月內上漲至20.87%(可能上漲20.87%)。6家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Pediatrix Medical Group (MD)?
Pediatrix Medical Group(MD)的最新分析師評級是多少？
The latest analyst rating for Pediatrix Medical Group (NYSE: MD) was provided by Truist Securities, and Pediatrix Medical Group maintained their hold rating.
Pediatrix Medical Group(紐約證券交易所代碼：MD)的最新分析師評級由Truist Securities提供，Pediatrix Medical Group維持其持有評級。
When is the next analyst rating going to be posted or updated for Pediatrix Medical Group (MD)?
Pediatrix Medical Group(MD)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pediatrix Medical Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pediatrix Medical Group was filed on October 11, 2023 so you should expect the next rating to be made available sometime around October 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Pediatrix Medical Group的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Pediatrix Medical Group的上一次評級是在2023年10月11日提交的，所以你應該預計下一次評級將在2024年10月11日左右的某個時候公佈。
Is the Analyst Rating Pediatrix Medical Group (MD) correct?
分析師對兒科醫療集團(MD)的評級正確嗎？
While ratings are subjective and will change, the latest Pediatrix Medical Group (MD) rating was a maintained with a price target of $16.00 to $15.00. The current price Pediatrix Medical Group (MD) is trading at is $12.41, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但Pediatrix Medical Group(MD)的最新評級保持不變，目標價在16.00美元至15.00美元之間。Pediatrix Medical Group(MD)目前的股價為12.41美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。